Life sciences - what to expect in 2023
We anticipate a year of reserved optimism in the life sciences industry for 2023. Despite uncertain financial markets and pricing...
Paul brings a calm, considered approach to complex tax and finance matters.
He specialises in finance transactions, ranging from complex structured finance to derivatives, bank and bond debt and other treasury transactions.
Paul also advises on corporate finance and restructurings, and helps clients resolve disputes with the UK tax authorities.
Clients often bring in Paul at a transaction’s earliest stages because of his ability to spot, explain and navigate through complicated tax issues. They appreciate his analytical skills, detailed grasp of accounting concepts and understanding of the technical complexities of financial instruments.
Freshfields Technology Quotient
Insights at the intersection of technology and the law
We anticipate a year of reserved optimism in the life sciences industry for 2023. Despite uncertain financial markets and pricing...
We anticipate a year of reserved optimism in the life sciences industry for 2023. Despite uncertain financial markets and pricing...
We anticipate a year of reserved optimism in the life sciences industry for 2023. Despite uncertain financial markets and pricing...
It has long been common practice in the UK for charities to establish wholly-owned companies through which to carry out trading...
The OECD has published a consultation on the exclusion of certain Financial Services entities from pillar one of its two-pillar solution...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net